Literature DB >> 11278889

Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha ). Functions of lipid kinase-deficient PI3Kalpha in signaling.

L Pirola1, M J Zvelebil, G Bulgarelli-Leva, E Van Obberghen, M D Waterfield, M P Wymann.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) are dual specificity lipid and protein kinases. While the lipid-dependent PI3K downstream signaling is well characterized, little is known about PI3K protein kinase signaling and structural determinants of lipid substrate specificity across the various PI3K classes. Here we show that sequences C-terminal to the PI3K ATP-binding site determine the lipid substrate specificity of the class IA PI3Kalpha (p85/p110alpha). Transfer of such activation loop sequences from class II PI3Ks, class III PI3Ks, and a related mammalian target of rapamycin (FRAP) into p110alpha turns the lipid substrate specificity of the resulting hybrid protein into that of the donor protein, while leaving the protein kinase activity unaffected. All resulting hybrids lacked the ability to produce phosphatidylinositol 3,4,5-trisphosphate in intact cells. Amino acid substitutions and structure modeling showed that two conserved positively charged (Lys and Arg) residues in the activation loop are crucial for the functionality of class I PI3Ks as phosphatidylinositol 4,5-bisphosphate kinases. By transient transfecion of 293 cells, we show that p110alpha hybrids, although unable to support lipid-dependent PI3K signaling, such as activation of protein kinase B/Akt and p70(S6k), retain the capability to associate with and phosphorylate insulin receptor substrate-1, with the same specificity and higher efficacy than wild type PI3Kalpha. Our data lay the basis for the understanding of the class I PI3K substrate selectivity and for the use of PI3Kalpha hybrids to dissect PI3Kalpha function as lipid and protein kinase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278889     DOI: 10.1074/jbc.M011330200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Exploring the specificity of the PI3K family inhibitor LY294002.

Authors:  Severine I Gharbi; Marketa J Zvelebil; Stephen J Shuttleworth; Tim Hancox; Nahid Saghir; John F Timms; Michael D Waterfield
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

2.  Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors:  Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

4.  Kinetic and structural analyses reveal residues in phosphoinositide 3-kinase α that are critical for catalysis and substrate recognition.

Authors:  Sweta Maheshwari; Michelle S Miller; Robert O'Meally; Robert N Cole; L Mario Amzel; Sandra B Gabelli
Journal:  J Biol Chem       Date:  2017-07-04       Impact factor: 5.157

5.  Drosophila target of rapamycin kinase functions as a multimer.

Authors:  Yong Zhang; Charles J Billington; Duojia Pan; Thomas P Neufeld
Journal:  Genetics       Date:  2005-10-11       Impact factor: 4.562

6.  Inhibition of protein phosphatase 2A activity by PI3Kγ regulates β-adrenergic receptor function.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Manveen K Gupta; Afshan K Hussain; Sathyamangla V Naga Prasad
Journal:  Mol Cell       Date:  2011-03-18       Impact factor: 17.970

Review 7.  Phosphatidylinositol 3-kinase: the oncoprotein.

Authors:  Peter K Vogt; Jonathan R Hart; Marco Gymnopoulos; Hao Jiang; Sohye Kang; Andreas G Bader; Li Zhao; Adam Denley
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 8.  Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis.

Authors:  Enrico Lupia; Luca Pigozzi; Alberto Goffi; Emilio Hirsch; Giuseppe Montrucchio
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

9.  PIK3CA somatic mutations in breast cancer: Mechanistic insights from Langevin dynamics simulations.

Authors:  Parminder K Mankoo; Saraswati Sukumar; Rachel Karchin
Journal:  Proteins       Date:  2009-05-01

Review 10.  Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design.

Authors:  Sandra B Gabelli; Diana Mandelker; Oleg Schmidt-Kittler; Bert Vogelstein; L Mario Amzel
Journal:  Biochim Biophys Acta       Date:  2009-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.